ClinicalTrials.Veeva

Menu

NIDEK Gonioscope GS-1 for Glaucoma

NYU Langone Health logo

NYU Langone Health

Status

Completed

Conditions

Glaucoma

Treatments

Other: NIDEK Gonioscope GS-1
Other: Standard Digital Gonioscopic Images

Study type

Interventional

Funder types

Other

Identifiers

NCT03715231
18-00429

Details and patient eligibility

About

The Gonioscope GS-1 is an ophthalmic camera with gonioscopic prism that is intended to capture, display and store images of the anterior chamber angle and its peripheral part. This study evaluates the efficiency of Gonioscope GS-1 in glaucoma patients.With the captured images, the glaucoma diagnosis and post-operative observation are enabled.

Enrollment

24 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with glaucoma or glaucoma suspect

Glaucoma Suspect

  • Glaucomatous optic neuropathy as described in the glaucoma patients below
  • AND/OR ocular hypertension (IOP > 21 mm Hg)
  • Normal visual field

Glaucoma Patients

  • Clinical characteristics of glaucoma: ONH abnormalities: global rim thinning, rim notch, or disc hemorrhage; RNFL defect
  • Typical glaucomatous field loss in reliable VF, reproducible glaucoma hemifield tests labeled outside normal limits on at least two consecutive tests.
  • Both eyes will be included, except in cases where only one eye meets study criteria

Exclusion criteria

  • Corneal opacities (scars, edema, etc.)
  • Pregnant or planning to become pregnant
  • Inability to fixate gaze

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

24 participants in 1 patient group

Glaucoma & Glaucoma Suspect Patients
Experimental group
Description:
Patients with Glaucomatous optic neuropathy
Treatment:
Other: Standard Digital Gonioscopic Images
Other: NIDEK Gonioscope GS-1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems